Apeiron is built on a financial base that has been provided by national and international private equity investors. In addition, several pharma companies have aquired a minority stage (GSK, Paladin, Medison, Gen Ilac, Dexcel) Furthermore, Apeiron has received or is entitled to get financial support from various Austrian and European support agencies.

Austria Wirtschaftsservice (AWS)

vienna business agency

Österreichische Forschungsförderungsgesellschaft (FFG)

European Investment Bank (EIB)